145012 - "Male lower urinary tract symptoms (LUTS) & the prostate - contemporary management"

This education activity is aimed at GPs and other health care providers to identify prostate specific antigen testing through the use of evidence-based tools and deliver safe management plans for patients presenting with lower urinary tract symptoms and after receiving prostate cancer treatment.

Relevance to General Practice

Needs Assessment – GPEx Prostate Cancer workshop, 21st September 2018 Hahndorf

Prostate cancer was the most commonly diagnosed cancer in Australia in 2014. In 2014, it was also the most commonly diagnosed cancer among males. It is estimated to become the second most commonly diagnosed cancer in 2018, while remaining the most commonly diagnosed cancer among males. In 2018, it is estimated that the risk of a male being diagnosed with prostate cancer by his 85th birthday will be one in seven....PLEASE REFER ATTACHED DOCUMENT FOR REMAINDER OF THE DOCUMENT

Learning outcomes

List the indications and limitations of prostate specific antigen (PSA) testing

Use evidence-based tools to help asymptomatic patients decide whether to proceed with PSA testing

Describe the initial approach to management of a male presenting with lower urinary tract symptoms

Develop a safe management plan for a patient after prostate cancer treatment

Discuss the possible complications of prostate cancer investigation and treatment

145012 - "Male lower urinary tract symptoms (LUTS) & the prostate - contemporary management"

Email me similar courses and CPD events